Timothy S. Chang, MD, PhD and Lisa L. Barnes, PhD, discuss health disparities in Alzheimer disease and related dementias and how to improve clinical outcomes for patients from underrepresented groups.
January FDA approvals include treatments for mood disorders, pertussis in infants, Alzheimer disease, and type 2 diabetes.
The risk of bedsores, or pressure injuries, is real in patients living in nursing homes. This column reviews 3 recent studies that question the “q2h repositioning” rule, validity of the Braden Scale, and special needs of patients with obesity.
The preliminary safety signal was identified by the CDC’s Vaccine Safety Datalink.
Increase in vaccination rate linked to fewer COVID-19 cases and deaths among residents, cases among staff in nursing homes.
Predictors of emergency department avoidance include lower income, being uninsured, poor or fair mental/physical health, and younger age.
An important new study offers much-needed data to inform older adults of the risks and benefits they must weigh when facing major surgery.
Toolkit provides guidance on the COVID-19 bivalent booster and oral antiviral therapeutics.
As people living with HIV begin to age, their risk of developing HIV-associated cognitive decline increases. A specific training program to help patients with HIV with speed of processing (SOP) may help stall those effects.
Those with a family history or higher self-perceived risk are more likely to participate.
To reduce benzodiazepine use postoperatively in older adults, researchers examined the effects of using melatonin instead.
Lecanemab is a humanized monoclonal antibody that works by selectively binding to, neutralizing and eliminating soluble toxic amyloid beta aggregates.
Compared with placebo, daily multivitamin-mineral supplementation resulted in a statistically significant benefit on global cognition.
Climate change can affect older patients with asthma, COPD, allergies, kidney disease, and other conditions.
Nearly half of patients at assisted living facilities showed significant weight loss early during the COVID-19 pandemic.
The cognitive assessment toolkit for early recognition of Alzheimer disease is being developed by the AAPA in collaboration with the Cleveland Clinic and PA Foundation.
Author describes symptoms of life threatening illness that might be mistaken for a normal part of the aging process in older patients.
GAPNA reviews studies on the links between dementia and cardiometabolic multimorbidity, atrial cardiopathy, and cardiovascular disease in midlife.
Highest risk for new diagnosis of Alzheimer disease within 360 days after diagnosis seen for those aged 85 years and older.
Clinicians need to be aware of their assumptions about patients based on age.